BRAINSTORM CELL THERAPEUTICS INC. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q1 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Brainstorm Cell Therapeutics Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q1 2025.
  • Brainstorm Cell Therapeutics Inc. Entity Common Stock, Shares Outstanding for the quarter ending March 27, 2025 was 6.52M shares, a 90.5% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2025 6.52M -61.8M -90.5% Mar 27, 2025 10-K 2025-03-31
Q3 2024 5.7M -43.3M -88.4% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 79.7M +34.7M +77.1% Aug 9, 2024 10-Q 2024-08-14
Q1 2024 68.3M +31.7M +86.3% Mar 27, 2024 10-K 2024-04-01
Q3 2023 49M +12.4M +34% Nov 10, 2023 10-Q 2023-11-14
Q2 2023 45M Aug 14, 2023 10-Q 2023-08-14
Q1 2023 36.7M +189K +0.52% Mar 28, 2023 10-K 2023-03-30
Q3 2022 36.5M Nov 14, 2022 10-Q 2022-11-14
Q1 2022 36.5M +168K +0.46% Mar 28, 2022 10-K 2022-03-28
Q4 2021 36.3M +557K +1.56% Nov 15, 2021 10-Q 2021-11-15
Q2 2021 36.3M +4.79M +15.2% Aug 5, 2021 10-Q 2021-08-05
Q1 2021 36.3M +6.88M +23.4% Apr 23, 2021 10-Q 2021-04-26
Q4 2020 35.7M +9.49M +36.2% Feb 4, 2021 10-K 2021-02-04
Q3 2020 31.6M +8.96M +39.6% Sep 30, 2020 10-Q 2020-10-15
Q2 2020 31.5M +8.98M +39.8% Jul 31, 2020 10-Q 2020-08-05
Q1 2020 29.4M +7.95M +37% May 4, 2020 10-Q 2020-05-07
Q4 2019 26.2M Feb 14, 2020 10-K 2020-02-18
Q3 2019 22.6M +1.9M +9.17% Nov 6, 2019 10-Q 2019-11-14
Q2 2019 22.6M +1.88M +9.1% Aug 7, 2019 10-Q 2019-08-13
Q1 2019 21.5M +2.42M +12.7% Mar 28, 2019 10-K 2019-04-01
Q3 2018 20.7M +1.86M +9.9% Oct 25, 2018 10-Q 2018-10-29
Q2 2018 20.7M +1.91M +10.2% Jun 30, 2018 10-Q 2018-07-23
Q1 2018 19.1M +382K +2.04% Mar 6, 2018 10-K 2018-03-08
Q3 2017 18.8M +155K +0.83% Oct 13, 2017 10-Q 2017-10-17
Q2 2017 18.8M +110K +0.59% Aug 7, 2017 10-Q 2017-08-14
Q1 2017 18.7M +33.9K +0.18% Mar 24, 2017 10-K 2017-03-29
Q3 2016 18.7M +190K +1.03% Nov 7, 2016 10-Q 2016-11-14
Q2 2016 18.7M +173K +0.94% Aug 8, 2016 10-Q 2016-08-11
Q1 2016 18.7M +260K +1.42% Mar 4, 2016 10-K 2016-03-09
Q3 2015 18.5M +3.22M +21.1% Nov 6, 2015 10-Q 2015-11-16
Q2 2015 18.5M -209M -91.9% Aug 10, 2015 10-Q 2015-08-13
Q1 2015 18.4M -158M -89.6% Mar 23, 2015 10-K 2015-03-26
Q3 2014 15.3M -161M -91.3% Nov 4, 2014 10-Q 2014-11-13
Q2 2014 227M +74.6M +48.9% Aug 4, 2014 10-Q 2014-08-12
Q1 2014 176M +25M +16.5% Mar 7, 2014 10-K 2014-03-27
Q3 2013 176M +176M Nov 12, 2013 10-Q 2013-11-14
Q2 2013 153M +4.31M +2.9% Jul 31, 2013 10-Q 2013-08-14
Q1 2013 151M +24.7M +19.5% Mar 8, 2013 10-K 2013-03-14
Q3 2012 0 -126M -100% Nov 14, 2012 10-Q 2012-11-13
Q2 2012 148M +25.3M +20.5% Aug 10, 2012 10-Q/A 2012-08-29
Q1 2012 127M Mar 9, 2012 10-K 2012-03-15
Q3 2011 126M Nov 9, 2011 10-Q 2011-11-14
Q2 2011 123M Aug 10, 2011 10-Q/A 2011-09-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.